Penis pump and Viagra prescriptions soar as NHS spends over £20MILLION helping blokes with erectile dysfunction
Click to share on Facebook (Opens in new window)
DOCTORS prescribed a record number of bedroom aids for blokes such as penis pumps and Viagra last year, figures show.
The NHS in England alone spent more than £20million helping men dealing with erectile dysfunction.
Sign up for Scottish Sun
newsletter
Sign up
1
Doctors prescribed a record number of bedroom aids for blokes such as penis pumps and Viagra last year
Credit: Alamy
A total of 24,231 erection devices, including vacuum pumps — as seen in 1997 comedy Austin Powers: International Man of Mystery — and constriction rings were prescribed in 2024/25, the NHS Business Services Authority revealed.
That was up by 10,000 on a decade ago.
And the £2.8million cost has doubled since 2015.
Meanwhile, prescriptions for drugs such as Viagra and Cialis reached 4.7million — up 100,000 on the year before — with a cost of £17.6million.
The NHS said erection problems are 'very common' in men over 40 and become more likely with age and illness.
A spokesman added: 'Effective erectile dysfunction treatment is important for both sexual and mental well-being.'
Dr Leyla Hannbeck, chief of the Independent Pharmacies Association, said the pumps were a useful option for people who cannot be prescribed Viagra.
She said: 'Viagra and Cialis interact with medicines used to treat angina and certain blood pressure medicines so alternatives are available, including pumps, where taking them is unsuitable.'
The findings come days after actress Dame Emma Thompson suggested sex should be prescribed on the NHS.
She spoke out at a a screening of her 2022 film Good Luck To You, Leo Grande — in which she plays a widow who hires a sex worker.
Bionic willies on the rise as more than 500 men with severe erectile dysfunction have £8,000 NHS operation
Dame Emma, 66, said: 'You need sex because it's part of our health plan, if you like.
'It should really be on the NHS.
'It's so good for you.'
Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
3 hours ago
- Daily Mail
Comatose man's secret lovers join forces to keep him alive - after only finding out about each other when he suffered a brain bleed
A comatose man's secret lovers have joined forces to keep him alive, despite finding out about one another after he had suffered a bleed on the brain. The two women, who had been with their partner for over two decades, were unaware of each other's existence until the 60-year-old suffered a bleed to the brain last October. Due to the brain injury, he developed a prolonged disorder of consciousness (PDOC) - a term used for patients in a coma or a vegetative state (VS). After being admitted to ICU, he was later transferred to a rehabilitation unit under the Hillingdon Hospitals NHS Foundation Trust, where he remains. The Trust had requested permission from the court to withdraw his clinically assisted hydration and nutrition, which would lead to his eventual death. However, the man's lovers, referred to as JG and MB, argued against the proposal, saying the man would have wished to keep living despite his vegetative state. The pair are also 'his bedside each day, provide emotional and physical care for him' and are 'very well attuned to his physical needs', the court was told. The Official Solicitor, who was present to represent YD's interest, also argued the 60-year-old would feel 'his life now is dignified because of the love and care provided to him by his partners. 'He would wish to continue in this way until the life of his body was ended by a process such as a heart attack, further stroke, or infection,' they added. Mrs Justice Theis ruled it was in YD's best interest to continue to receive the clinically assisted treatment after considering the matter 'through a wide best interests lens'. The judge acknowledged how 'striking' it had been that even though the women had known YD for 20 and 24 years respectively, they had been unaware of one another. Yet, despite not having known one another until the incident, they were 'able to independently confirm many common features' about his wishes and beliefs, the judge said. 'In particular, regarding the depth of his interest in the spiritual world and his limitless curiosity about such matters that he held strong beliefs about. 'YD has long held beliefs about the healing power of the mind, body and soul, and to understand and, if required, push established boundaries based on his learning and understanding. 'From their descriptions, YD was a compassionate, private person who was a fiercely independent thinker about a wide range of issues, in particular regarding the spiritual world and healing. 'His long-standing interest in the healing power of the mind, spirit or soul would very likely be values that would inform his decision if he had capacity,' they added. 'The changes that have been observed he would regard as positive signs and that he had the potential to make further changes.' Mrs Justice Theis also added how the 60-year-old's beliefs in healing were 'likely to be relevant' and would have informed his decision if he had the capacity. They continued that it would have been a factor in his 'wishing' to continue to receive clinically assisted nutrition and hydration. Noting his participation in spiritual healing, she said: 'YD would also likely factor in, due to his long-standing beliefs in such matters, that others believe they are in communication with him.' The judge concluded while there would be burdens for YD in continuing treatment, both long-term and short-term, it would, 'most importantly', preserve his life. And even though his awareness is 'extremely limited' and that 'there may be little or no further improvement', they concluded: 'It is far from clear that in the circumstances YD is in, he would regard his continued existence as a burden.' 'There is a strong presumption in favour of preserving life which, in my judgment, having carefully evaluated the evidence in this unusual case, the Trust has not discharged.' The hospital's application was refused.
Scottish Sun
4 hours ago
- Scottish Sun
Cases of killer virus that makes the body ‘fold in on itself' soaring in UK – after virus sparks pandemic fears in China
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) CASES of a killer virus that can make the body 'fold in on itself' have increased in the UK, health chiefs have warned. There were 73 cases of chikungunya, a mosquito-borne disease that causes crippling joint pain, between January and June 2025 in England, Wales and Northern Ireland - the highest number ever recorded. Sign up for Scottish Sun newsletter Sign up 5 Chikungunya is spread by the tiger mosquito Credit: Getty 5 This is over double the 27 cases reported during the same period in 2024, UK Health Security Agency (UKHSA) data from its most recent travel-associated infection report suggests. The first cases of the oropouche have also been reported in the UK, which were all linked to travel from Brazil. The oropouche virus, dubbed 'sloth fever', circulates between primates, sloths, and birds in the wild - before it is occasionally passed to humans by midges and mosquitoes. It is primarily found in the Amazon basin in South America, but in recent years has started spreading more widely around the Americas. Health officials have since urged people to take precautions against insect bites while on holiday, as cases of both infections surge. Chikungunya spreads through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus species. The virus is rarely deadly, but can cause serious disease spread by the in the very young, older people and those with other underlying illnesses. Typical symptoms include: Excruciating joint pain, which can leave victims hunched or folded over in agony High fever Headache Muscle aches Nausea Fatigue Red, bumpy rash Swelling in the joints, particularly the hands and feet In severe cases, the joint pain can mimic arthritis, leaving sufferers temporarily disabled for months or even years. Oropouche virus The illness mainly occurs in Africa and Asia, specifically southern Asia, although cases have been reported in Europe and parts of North America. However, this year there have been outbreaks in the Americas and Asia, with surges in China and the Indian Ocean islands of Reunion, Mayotte and Mauritius. The majority of UK cases reported this year were linked to travel to Sri Lanka, India and Mauritius. All cases were reported in England, primarily in London. There is currently no risk of onward transmission of chikungunya, as the two species of mosquito that transmit the disease are not established in the UK, UKHSA said. Meanwhile, more than 7,000 people have been struck down by the virus in China since June 2025, according to national health officials. 5 Patient with joint deformities of the hands 6 years after confirmed chikungunya virus (Credit: SehatHub) 5 Experts are urging people to use insect repellent while travelling Credit: Getty The majority of cases have been reported in Foshan, a city in southern Guangdong province, where officials have since rolled out Covid-style lockdowns in a desperate bid to stop the virus from spiralling out of control. At least 12 other cities in the southern Guangdong province have also reported infections. Hong Kong and Taiwan have also reported cases. Dr Philip Veal, consultant in public health at UKHSA, said: "Chikungunya can be a nasty disease and we're seeing a worrying increase in cases among travellers returning to the UK. "While this mosquito-borne infection is rarely fatal, it can cause severe joint and muscle pain, headaches, sensitivity to light and skin rashes. "Thankfully, symptoms usually improve within a few weeks, but joint pain may last for months or longer." He added: "It is essential to take precautions against mosquito bites when travelling. "Simple steps, such as using insect repellent, covering up your skin and sleeping under insecticide-treated bed nets can greatly reduce the risk." Two chikungunya vaccines are approved for use in the UK and are available to buy after an assessment at a private travel clinic. Meanwhile, three cases of oropouche virus have been detected by UKHSA. How concerning is this outbreak in China? Though tactics adopted by authorities in China hark back to lockdown measures five years ago, chikungunya "does not pose the same level of pandemic threat as a virus like Covid-19", according to Prof Tom Solomon, director of The Pandemic Institute in Liverpool. Dr César López-Camacho, from the Jenner Institute at the University of Oxford, added: 'It is extremely unlikely to cause a pandemic in the traditional sense, as chikungunya does not spread from person to person. "However, it can cause large regional outbreaks, especially when introduced to mosquito-rich, low-immunity settings, like what we are probably seeing in China." The risk to the UK from this outbreak is "currently low" as Aedes mosquitoes, which tend to carry the virus, aren't widespread here. "But we do need to watch closely, as climate change and global travel are expanding the range of these mosquitoes, and with it, the viruses they carry," Dr López-Camacho warned. 'It is also important that genetic sequencing of the virus in this outbreak is carried out. "In past outbreaks, mutations have helped chikungunya adapt to new mosquito species. "If the virus has changed, we need to ensure current vaccines still offer protection." Brits travelling to China amidst the outbreak should "be cautious", the disease expert said. He continued: "The US Centre for Disease Control and Prevention has issued a Level 2 travel alert, recommending travellers use insect repellent, wear long sleeves, and stay in screened or air-conditioned accommodation. "Travellers returning from affected areas who develop fever and joint pain should seek medical attention and mention their recent travel." People travelling to high-risk areas where outbreaks of the virus often occur can get vaccinated against chikungunya at a travel clinic. But Prof Solomon noted: "There have been reports of serious side effects in people over the age of 65. "As such, the vaccine is currently recommended for travellers under 65 visiting high-risk areas." The flu-like illness can cause a fever, headaches, joint pain, muscle pain, chills, nausea and vomiting. Officials urged anyone who becomes unwell with these symptoms after travel to affected areas, including parts of Central and South America and the Caribbean, to seek urgent medical advice. According to the World Health Organisation (WHO), before late 2023, oropouche virus was mostly reported near the Amazon rainforest area. However, in 2024, Brazil, Bolivia, Colombia, Cuba, Guyana, Peru and the Dominican Republic reported locally transmitted cases of the disease. The UKHSA report also shows a rise in travel-associated cholera cases in the UK, with eight cases in the first half of the year compared to just one in 2024. Most cases were linked with travel to India and Ethiopia. There was also a 67 per cent decrease in the number of dengue cases reported in England, Wales and Northern Ireland from January to June. And there were just four cases of zika virus during the period, down from nine in 2024. 5 Oropouche virus, dubbed 'sloth fever', circulates between primates, sloths, and birds in the wild Credit: Dick van Duijn / Animal News Agency
Daily Mirror
4 hours ago
- Daily Mirror
Six Oropouche symptoms easily mistaken for flu after deadly virus first found in UK
UKHSA confirms first UK cases of Oropouche virus in travellers from Brazil. With flu-like symptoms, experts warn holidaymakers to know the signs and take precautions British travellers are being urged to stay vigilant after the UK recorded its first-ever cases of Oropouche virus (OROV), a mosquito and midge-borne infection that can easily be mistaken for the flu. According to the latest UK Health Security Agency (UKHSA) report, three cases of Oropouche were identified in travellers returning from Brazil between January and June 2025. While relatively rare, the virus has been spreading across parts of South and Central America and the Caribbean, with Brazil reporting the largest outbreaks. The infection typically causes high fever, chills, headache, joint pain, and muscle aches - symptoms that closely resemble common viral illnesses, making it easy to misdiagnose. It comes after the NHS warns mouth symptom could be life-shortening disease. READ MORE: Urgent warning issued as dogs and foxes die after eating 'poison' in Devon park Dr Philip Veal, Consultant in Public Health at UKHSA, stressed the importance of taking travel precautions. 'If a person becomes unwell with these symptoms following travel to affected areas, they should seek urgent medical advice,' he said. Pregnant travellers, in particular, are advised to be cautious due to recent concerns about Oropouche virus infection during pregnancy. Symptoms Fever or chills Severe headache Muscle aches or joint pain Nausea or vomiting Rash Diarrhoea Get health warnings straight to your WhatsApp! As the world grapples with the threats of Covid-19, mpox and more, the Mirror has launched its very own Health & Wellbeing WhatsApp community where you'll get health warnings and news straight to your phone. We'll send you the latest breaking updates and exclusives all directly to your phone. Users must download or already have WhatsApp on their phones to join in. All you have to do to join is click on this link, select 'Join Chat' and you're in! We may also send you stories from other titles across the Reach group. We will also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose Exit group. If you're curious, you can read our Privacy Notice. The rise in Oropouche cases comes alongside other travel-related infections that UKHSA has been tracking. Chikungunya - a mosquito-borne virus causing sudden fever and debilitating joint pain - has seen a sharp increase, with 73 cases reported in England in the first half of 2025. Most affected travellers had returned from Sri Lanka, India, and Mauritius, where outbreaks continue. Although the UK's climate prevents local mosquitoes from transmitting the disease, severe symptoms can linger for months, particularly joint pain, which affects up to 12 percent of patients even three years after infection. For those planning trips to higher-risk regions, two chikungunya vaccines are now available in the UK: IXCHIQ® for adults aged 18 to 59 and Vimkunya® for individuals 12 and older. UKHSA recommended consulting a travel clinic to discuss suitability before travelling. The Travel-associated Infections report also highlights a worrying increase in cholera cases, rising from one case in 2024 to eight in the first half of 2025, largely linked to travel to India and Ethiopia. Dengue and Zika virus cases, by contrast, have fallen, with 161 dengue cases and just four Zika cases reported across England, Wales, and Northern Ireland during the same period. Meningococcal serogroup W (MenW) disease has also been noted among UK travellers, particularly those visiting Saudi Arabia for Umrah and Hajj. The potentially deadly infection can leave survivors with severe lifelong health complications, and vaccination with MenACWY is strongly advised for pilgrims and their close contacts. UKHSA recommends that travellers consult the Travel Health Pro website at least four to six weeks before departure. The site provides comprehensive advice on health risks worldwide, helping travellers take preventive measures such as vaccinations, mosquito bite avoidance, and timely medical guidance if symptoms appear.
